VNDA - Why Is Vanda Pharmaceuticals Stock Trading Higher Today? | Benzinga
Tuesday, the FDA approved Vanda Pharmaceuticals Inc’s (NASDAQ:VNDA) Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
Fanapt is an atypical antipsychotic agent that has been used for the acute treatment of patients with schizophrenia since its FDA approval in 2009.
Bipolar disorder is a psychiatric chronic condition affecting approximately 2.8% of the U.S. adult population, with 83% of them classified as severe.
Bipolar disorder is a group of disorders that are characterized by periods of elevated mood alternating with periods of depressed mood.
Patients with bipolar I disorder with manic or mixed ...